Patient Prostate Cancer Journey Part 1: A Urology Exam Reveals Unexpected Results November 1, 2022 The day began positively average and uneventful. Dressed and ready for work, I mentioned to my wife, "I'll be home a bit later than usual - I have an appo... Continue Reading
Can a genetic test improve prostate cancer treatment decisions? A patient story. October 25, 2022 https://myriad-1.wistia.com/medias/w9go8af7h5 How can a prognostic test inform care plans for a patient with prostate cancer? Richard Tyus and his uro... Continue Reading
Consistent data matters. Prolaris® is the best answer for your prostate cancer patients. Submit the form below to learn why. August 26, 2022 Treating prostate cancer can be hard, Prolaris makes it easy Knowing if your prostate cancer patients are safe for active surveillance or if they would bene... Continue Reading
Myriad Genetics is committed to being your partner of choice August 5, 2022 Against the backdrop of recent shifts in the genetic testing industry, we would like to take a minute to reiterate Myriad Genetics’ determination to bring cl... Continue Reading
Understanding Prolaris test results June 17, 2022 After a prostate cancer diagnosis, choosing an appropriate treatment path can be incredibly stressful for you and your loved ones. Further complicating the pro... Continue Reading
What is the Prolaris test? June 10, 2022 The Prolaris test is a genetic test for untreated men with prostate cancer that can determine how quickly cancer is growing. Prolaris helps provide clarity abo... Continue Reading
Being a Caregiver June 3, 2022 A prostate cancer diagnosis can be devastating for you and your family, but you have options. At this confusing time, you may have questions about how to help ... Continue Reading
What is Active Surveillance May 27, 2022 Some prostate tumors grow very slowly and never cause health problems. Active surveillance or watchful waiting involves regular testing and monitoring. A... Continue Reading
Prostate Cancer Symptoms May 20, 2022 Early prostate cancer generally does not exhibit any symptoms. Oftentimes, an initial diagnosis is made by a doctor during an annual exam of the prostate. Men ... Continue Reading
What is a Gleason Score May 13, 2022 Pathologists review biopsy tissue and assign it a Gleason grade based on the appearance of the cells. If cancer is present, it will be assigned two Gleason gra... Continue Reading
Understanding PSA May 6, 2022 What is PSA? PSA is a protein (called prostate specific antigen) produced by cells that line the small... Continue Reading
Prostate cancer on the rise in 2022 April 29, 2022 Prostate cancer is a very common diagnosis. Did you know prostate cancer is estimated to be the second most common cancer diagnosis in American men?According t... Continue Reading
Genetic insights for more actionable and personalized prostate cancer March 25, 2022 Connect with us The AUA National meeting is centered around the exploration of the latest and groundbreaking advancements in urology, and th... Continue Reading
Prolaris® is advancing prostate cancer care at ASCO GU February 11, 2022 Prolaris now has 2 validated thresholds to make treatment decisions easier Prolaris is a prognostic, tumor-based biomarker test that measures the aggressive... Continue Reading
Prolaris® is Helping Urologists Reimagine Prostate Cancer Care November 2, 2021 This year’s LUGPA theme centers on re-imagining the practice of Urology. What better time than now to discover how incorporating genetic testing into your pr... Continue Reading